NCT06630819 is a NA clinical trial of 1.8 ml of 4% Articaine in Buccal Infiltration, sponsored by Qassim University.

Who is sponsoring NCT06630819?

NCT06630819 is sponsored by Qassim University.

What drugs are being tested in NCT06630819?

Interventions in NCT06630819: 1.8 ml of 4% Articaine, 3.6 ml of 4% Articaine.

What condition does NCT06630819 study?

NCT06630819 studies Buccal Infiltration, Articaine, Anesthesia.

Is NCT06630819 still recruiting?

NCT06630819 is currently recruiting now. Last updated 29 May 2025.

Last reviewed 2025-05-29 · How we verify

NCT06630819

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Buccal Infiltration of Different Volumes of Articaine for Extraction.

Recruiting now NA Last updated 29 May 2025

What this trial tests

NA trial testing 1.8 ml of 4% Articaine in Buccal Infiltration in 114 participants. Currently enrolling.

Timeline

24 November 2024

Primary endpoint
2 May 2026

2 May 2026

Quick facts

Lead sponsor	Qassim University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	114
Start date	24 November 2024
Primary completion	2 May 2026
Estimated completion	2 May 2026
Sites	2 locations across Saudi Arabia

Drugs / interventions tested

1.8 ml of 4% Articaine
3.6 ml of 4% Articaine

Conditions studied

Buccal Infiltration — all drugs for Buccal Infiltration →
Articaine — all drugs for Articaine →
Anesthesia — all drugs for Anesthesia →

Sponsor

Qassim University

Who can join

18 and older, any sex, with Buccal Infiltration or Articaine. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compares the effectiveness of two different volumes of buccal infiltration of Articaine for the extraction of mandibular posterior teeth. One group receives buccal infiltration of 1.8 ml of 4% Articaine and the other group receives buccal infiltration of 3.6 ml of 4% Articaine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Qassim University trials

Trials by the same sponsor.

NCT07400432 — Acute Effects of Moderate-Intensity Continuous Exercise Versus HIIT on Cognitive Performance and Psychophysiological Res · NA · enrolling by invitation
NCT07055659 — Enhancing Oral Hygiene in Children Through an Innovative Motivational Model · NA · active not recruiting
NCT06873230 — Assessment of Empathy Levels in Dental Hygiene Students and Interns · not yet recruiting
NCT06891495 — Evaluating an AI-Generated Health Podcast · recruiting
NCT07443007 — Effects of Balance, Plyometric, and Combined Plyometric-Balance Training in Pediatric Burn Survivors · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06630819 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Qassim University
Last refreshed: 29 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06630819.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing